Search research articles
Contact Us
Filters
Showing results (21-30 of 104) with videos related to
Page
of 11
Sort By:
Hepatology (Baltimore, Md.)
|
October 20, 2023
Reply: Contrasting effect of iron supplementation in protoporphyria
Cynthia Levy, Amy K Dickey, Karl E Anderson, et al.
The American Journal of the Medical Sciences
|
October 4, 2021
Acute Hepatic Porphyrias: "Purple Flags"-Clinical Features That Should Prompt Specific Diagnostic Testing
Karl E Anderson, Robert J Desnick, M Felicity Stewart, et al.
The Journal of Nutrition
|
December 25, 2008
Lean body mass, not estrogen or progesterone, predicts peak bone mineral density in premenopausal women
Lee-Jane W Lu, Fatima Nayeem, Karl E Anderson, et al.
European Journal of Nutrition
|
September 20, 2019
Soy isoflavones interact with calcium and contribute to blood pressure homeostasis in women: a randomized, double-blind, placebo controlled trial
Lee-Jane W Lu, Nai-Wei Chen, Fatima Nayeem, et al.
Current Protocols
|
February 10, 2025
Porphyria Diagnostics Part 2: Essential Biochemical Testing for Diagnosis of the Porphyrias
Vaithamanithi-Mudumbai Sadagopa Ramanujam, Akshata Moghe, Ruksana Huda, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
September 30, 2010
Alkaline phosphatase and percentage body fat predict circulating C-reactive protein in premenopausal women
Fatima Nayeem, Karl E Anderson, Manubai Nagamani, et al.
Molecular Genetics and Metabolism
|
December 14, 2005
delta-Aminolevulinate dehydratase (ALAD) porphyria: the first case in North America with two novel ALAD mutations
Reiko Akagi, Noriko Kato, Rikako Inoue, et al.
Nutrition Research (New York, N.Y.)
|
August 18, 2019
Daidzein and genistein have differential effects in decreasing whole body bone mineral density but had no effect on hip and spine density in premenopausal women: A 2-year randomized, double-blind, placebo-controlled study
Fatima Nayeem, Nai-Wei Chen, Manubai Nagamani, et al.
Photodermatology, Photoimmunology & Photomedicine
|
November 8, 2007
Hans Gunther and his disease
Pankaj Madan, Christian P Schaaf, Prem Vardhan, et al.
Nutrition and Cancer
|
December 15, 2005
Effect of a soymilk supplement containing isoflavones on urinary F2 isoprostane levels in premenopausal women
Sukwan Nhan, Karl E Anderson, Manubai Nagamani, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 104) with videos related to
Sort By:
Page
of 11
Hepatology (Baltimore, Md.)
|
October 20, 2023
Reply: Contrasting effect of iron supplementation in protoporphyria
Cynthia Levy, Amy K Dickey, Karl E Anderson, et al.
The American Journal of the Medical Sciences
|
October 4, 2021
Acute Hepatic Porphyrias: "Purple Flags"-Clinical Features That Should Prompt Specific Diagnostic Testing
Karl E Anderson, Robert J Desnick, M Felicity Stewart, et al.
The Journal of Nutrition
|
December 25, 2008
Lean body mass, not estrogen or progesterone, predicts peak bone mineral density in premenopausal women
Lee-Jane W Lu, Fatima Nayeem, Karl E Anderson, et al.
European Journal of Nutrition
|
September 20, 2019
Soy isoflavones interact with calcium and contribute to blood pressure homeostasis in women: a randomized, double-blind, placebo controlled trial
Lee-Jane W Lu, Nai-Wei Chen, Fatima Nayeem, et al.
Current Protocols
|
February 10, 2025
Porphyria Diagnostics Part 2: Essential Biochemical Testing for Diagnosis of the Porphyrias
Vaithamanithi-Mudumbai Sadagopa Ramanujam, Akshata Moghe, Ruksana Huda, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
September 30, 2010
Alkaline phosphatase and percentage body fat predict circulating C-reactive protein in premenopausal women
Fatima Nayeem, Karl E Anderson, Manubai Nagamani, et al.
Molecular Genetics and Metabolism
|
December 14, 2005
delta-Aminolevulinate dehydratase (ALAD) porphyria: the first case in North America with two novel ALAD mutations
Reiko Akagi, Noriko Kato, Rikako Inoue, et al.
Nutrition Research (New York, N.Y.)
|
August 18, 2019
Daidzein and genistein have differential effects in decreasing whole body bone mineral density but had no effect on hip and spine density in premenopausal women: A 2-year randomized, double-blind, placebo-controlled study
Fatima Nayeem, Nai-Wei Chen, Manubai Nagamani, et al.
Photodermatology, Photoimmunology & Photomedicine
|
November 8, 2007
Hans Gunther and his disease
Pankaj Madan, Christian P Schaaf, Prem Vardhan, et al.
Nutrition and Cancer
|
December 15, 2005
Effect of a soymilk supplement containing isoflavones on urinary F2 isoprostane levels in premenopausal women
Sukwan Nhan, Karl E Anderson, Manubai Nagamani, et al.
Page
of 11